Sola Dx’s shareholders, Chiara Herzog and Martin Widschwendter, are making a significant contribution to a new international concept in aging research. In doing so, the researchers are opening up new avenues for the prevention of age-related diseases.

Link to the paper

Researchers from the EUTOPS Institute at the University of Innsbruck have contributed to a new international framework for aging research using biomarkers. By developing a structure for assessing biomarkers, the researchers aim to better define biological aging. This could enable new ways to prevent age-related diseases.

As the population ages, diseases like cancer, dementia, and cardiovascular disease are rising, straining healthcare systems. Research since the 1930s suggests the aging process can be slowed or reversed, like through calorie restriction in mice. To apply this to humans and improve quality of life, biological aging must be defined and understood.

Biomarkers are objective biological metrics that provide insight into a biological process. The joint first author, Dr Chiara Herzog, from the EUTOPS Institute and Prof Martin Widschwendter, Head of the EUTOPS Insitute, together with over 20 other aging experts, systematically adapted and expanded existing biomarker frameworks to define “biomarkers of aging” and their clinical use. Their paper was published on August 31 in Cell.